GO:0009968 negative regulation of signal transduction: Signaling Brakes, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0009968 (negative regulation of signal transduction) describes any process that stops, prevents, or reduces the frequency, rate, or extent of signal transduction.
Negative regulation is essential for preventing excessive or prolonged signaling, and its failure contributes to cancer, autoimmunity, and developmental disorders.
Key negative regulators include SOCS proteins, Cbl ubiquitin ligases, phosphatases, and plant phytochrome-interacting factors.
The process operates through diverse mechanisms such as ubiquitin-mediated receptor degradation, dephosphorylation, and sequestration of signaling intermediates.
CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of negative regulators in disease and development.
Understanding negative regulation informs therapeutic strategies targeting aberrant signaling in cancer and inflammatory diseases.

Description

Signal transduction is the process by which cells convert extracellular cues into intracellular responses, and its precise control is vital for normal physiology. Negative regulation of signal transduction (GO:0009968) encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of signal transduction. This counterbalancing mechanism ensures that signaling pathways are not hyperactivated, which would otherwise lead to pathological outcomes such as uncontrolled cell proliferation or chronic inflammation. Research into negative regulators has revealed diverse molecular strategies, including the induction of feedback inhibitors like SOCS proteins in cytokine signaling and the ubiquitin-mediated degradation of activated receptors by Cbl proteins. In plants, phytochrome signaling networks similarly rely on negative regulation to modulate light responses. The importance of this GO term extends to development, immunity, and disease, making it a focal point for both basic and translational research.

negative regulation of signal transduction At A Glance

GO ID GO:0009968
GO term negative regulation of signal transduction
Ontology biological_process
Synonym down regulation of signal transduction; inhibition of signal transduction; negative regulation of signaling pathway
Major function Attenuation or termination of intracellular signaling cascades
Biological context Cytokine signaling, immune responses, plant light signaling, angiogenesis
Key regulators SOCS proteins, Cbl ubiquitin ligases, phosphatases, phytochrome-interacting factors
Disease relevance Cancer, autoimmunity, inflammatory diseases, developmental disorders

What Is GO:0009968?

According to the Gene Ontology, negative regulation of signal transduction (GO:0009968) is any biological process that stops, prevents, or reduces the frequency, rate, or extent of signal transduction. It includes mechanisms such as down-regulation, inhibition, or suppression of signaling pathways, and is synonymous with terms like negative regulation of signaling pathway.

Why Is negative regulation of signal transduction Important in Cell Biology?

Negative regulation of signal transduction is crucial because it prevents excessive or prolonged signaling that can lead to diseases such as cancer, autoimmunity, and chronic inflammation. It also fine-tunes developmental processes and environmental responses, as seen in plant phytochrome signaling and immune responses in Drosophila. Without proper negative regulation, pathways like cytokine signaling can become constitutively active, driving pathological cell growth and survival.
Prevents hyperactivation of cytokine signaling, which is linked to autoimmune diseases and cancers.
Controls immune responses to avoid excessive inflammation and tissue damage.
Regulates angiogenesis by modulating VEGF receptor signaling.
Essential for plant development and light responses through phytochrome signaling.
Dysregulation contributes to oncogenesis via loss of feedback inhibitors like SOCS proteins.
Cbl ubiquitin ligases negatively regulate receptor tyrosine kinases, affecting cell proliferation.
Involved in salt stress responses in plants through phytohormone signal transduction.
Provides targets for therapeutic intervention in inflammatory and neoplastic diseases.
Helps maintain homeostasis by balancing positive and negative signals.
Key to understanding bacterial signal transduction networks, e.g., Pho regulation.

What Happens During negative regulation of signal transduction?

Induction of Feedback Inhibitors
In simple terms: When a signal is too strong, the cell makes inhibitor proteins to turn it down.
A primary mechanism of negative regulation is the induction of feedback inhibitors. For example, cytokine signaling induces SOCS (suppressor of cytokine signaling) proteins, which then inhibit the JAK-STAT pathway by binding to JAK kinases or cytokine receptors. Similarly, in Drosophila immune responses, negative regulators are upregulated to prevent excessive activation.
Ubiquitin-Mediated Degradation
In simple terms: Tagging signaling proteins with ubiquitin marks them for destruction, stopping the signal.
Cbl ubiquitin ligases negatively regulate signal transduction by ubiquitinating activated receptor tyrosine kinases, leading to their degradation and termination of signaling. This process is critical for controlling growth factor and cytokine signaling.
Dephosphorylation by Phosphatases
In simple terms: Enzymes remove phosphate groups from signaling proteins, turning them off.
Protein phosphatases counteract kinase activities by dephosphorylating key signaling intermediates. For instance, in activin signaling, phosphatases negatively regulate the pathway to modulate cellular responses.
Sequestration and Compartmentalization
In simple terms: Signaling molecules are trapped or moved away so they cannot interact.
Negative regulation can occur through sequestration of signaling components. In plant phytochrome signaling, phytochrome-interacting factors (PIFs) are degraded or sequestered to attenuate light responses. Similarly, in bacterial Pho regulation, negative regulators modulate the signal transduction network.

Key Genes Involved in GO:0009968 negative regulation of signal transduction

Key genes and proteins involved in negative regulation of signal transduction include SOCS family members, Cbl ubiquitin ligases, phosphatases, and plant phytochrome-interacting factors.
GeneMajor RoleResearch Relevance
SOCS1Inhibits JAK-STAT cytokine signalingAutoimmunity, cancer, inflammation
SOCS3Negatively regulates cytokine signalingInflammation, metabolic disorders
CBLUbiquitin ligase targeting receptor tyrosine kinasesCancer, signal transduction
CBLBUbiquitin ligase, negative regulator of T cell signalingAutoimmunity, cancer
PTPN1Protein tyrosine phosphatase, negative regulator of insulin signalingDiabetes, cancer
PTPN11Phosphatase, modulates growth factor signalingDevelopmental disorders, cancer
PHYBPhytochrome B, negative regulator of shade avoidancePlant light signaling
PIF3Phytochrome-interacting factor, negative regulator of photomorphogenesisPlant development
PIF4Transcription factor, negatively regulated by phytochromePlant growth
SPRYSprouty proteins inhibit RTK signalingDevelopment, cancer
DUSP1Dual-specificity phosphatase, inactivates MAPKsInflammation, cancer
PIAS1Protein inhibitor of activated STAT, negative regulator of STATImmune regulation
CISHCytokine-inducible SH2-containing protein, inhibits STAT5Immune regulation
SHP1Phosphatase, negative regulator of hematopoietic signalingAutoimmunity, leukemia
SHP2Phosphatase, both positive and negative roles in signalingCancer, development
PHOBacterial Pho regulon negative regulatorBacterial signal transduction
TAB1Negative regulator of TLR signalingInflammation

How Is negative regulation of signal transduction Regulated?

Negative regulation of signal transduction is itself tightly regulated. For example, SOCS proteins are induced by cytokines and then feedback to inhibit the same pathway, creating a negative feedback loop. In plants, phytochrome signaling is modulated by light quality and duration, affecting the stability of PIFs. Additionally, Cbl ubiquitin ligases are regulated by phosphorylation and interacting proteins, which control their activity toward receptors.

negative regulation of signal transduction and Human Disease

GeneDisease / BiologyPotential Experimental Model
SOCS1Cancer, autoimmunitySOCS1 knockout mice, cancer cell lines
CBLLeukemia, cancerCbl knockout mice, hematopoietic cells
PTPN11Noonan syndrome, leukemiaPtpn11 knock-in mice, patient-derived cells
PHYBPlant developmentphyB mutants in Arabidopsis
SOCS3Inflammation, obesitySocs3 conditional knockout mice
Cancer
Loss of negative regulators such as SOCS proteins or Cbl ubiquitin ligases leads to hyperactivation of signaling pathways, promoting tumorigenesis. For instance, SOCS1 silencing is associated with various cancers, and Cbl mutations are found in leukemia.
Autoimmune and Inflammatory Diseases
Defective negative regulation of cytokine signaling results in excessive inflammation and autoimmunity. SOCS1-deficient mice die from severe inflammatory disease, and polymorphisms in SOCS genes are linked to autoimmune conditions.
Developmental Disorders
Mutations in negative regulators like PTPN11 cause developmental disorders such as Noonan syndrome, highlighting the importance of signal attenuation in development.
Plant Stress Responses
In plants, negative regulation of phytohormone signaling affects salt stress tolerance. For example, Sophora alopecuroides under salt stress shows altered phytohormone signal transduction, including negative regulation components.

From negative regulation of signal transduction-Related Genes to Experimental Models

Research QuestionSuitable Model
Does SOCS1 negatively regulate JAK-STAT in vivo?SOCS1 knockout mouse
How does Cbl ubiquitination affect receptor degradation?Cbl knockout cell lines
What is the role of PTPN11 in development?Ptpn11 point mutation knock-in mouse
How does phytochrome B regulate light signaling?phyB mutant Arabidopsis
Does SOCS3 overexpression suppress inflammation?SOCS3 transgenic mouse
What is the impact of Cbl-b on T cell activation?Cblb knockout mouse

How to Study the negative regulation of signal transduction Process

MethodWhat It MeasuresTypical Application
CRISPR knockout screenLoss-of-function effects on signalingIdentify negative regulators
PhosphoproteomicsPhosphorylation changesMap signaling networks
Luciferase reporterPathway activityTest negative regulators
Co-IPProtein-protein interactionsValidate SOCS-JAK binding
RNA-seqTranscriptional changesAssess feedback inhibitor induction
Western blotProtein levels and phosphorylationConfirm degradation or inhibition
Flow cytometryCell surface receptor levelsMeasure receptor downregulation
CRISPR Knockout Screens
Genome-wide CRISPR knockout screens can identify negative regulators of signal transduction by selecting for cells with hyperactive signaling. For example, knocking out SOCS genes may enhance cytokine signaling.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics quantifies changes in phosphorylation upon perturbation of negative regulators, revealing affected pathways.
Reporter Assays
Luciferase reporters driven by signaling-responsive promoters measure the activity of pathways in real time, useful for studying negative regulation.
Co-Immunoprecipitation
Co-IP identifies interactions between negative regulators and their targets, such as SOCS binding to JAK kinases.

How CRISPR Can Be Used to Study GO:0009968 negative regulation of signal transduction

Knockout

CRISPR knockout of negative regulators such as SOCS1 or CBL leads to hyperactivated signaling, providing models to study their function in disease.

Point Mutation

Point mutations in negative regulators (e.g., PTPN11) can mimic human disease alleles, allowing study of specific signaling defects.

Knock-in

Knock-in of tagged negative regulators (e.g., GFP-SOCS1) enables live-cell imaging and interaction studies.

Overexpression

Overexpression of negative regulators like SOCS3 can suppress signaling and is used to test therapeutic potential.

How EDITGENE Supports negative regulation of signal transduction Research

Researchers studying negative regulation of signal transduction-related genes often need to determine whether a candidate gene is causally involved in attenuating signaling and how its loss or mutation affects disease phenotypes. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of signal transduction research.

Frequently Asked Questions About negative regulation of signal transduction

It is any process that stops, prevents, or reduces the frequency, rate, or extent of signal transduction, as defined by GO:0009968.
Key genes include SOCS1, SOCS3, CBL, CBLB, PTPN1, PTPN11, and plant genes like PHYB and PIF3.
It works through mechanisms such as feedback inhibition, ubiquitin-mediated degradation, dephosphorylation, and sequestration of signaling components.
It prevents excessive signaling that can lead to cancer, autoimmunity, and developmental disorders.
Cancers, autoimmune diseases, inflammatory conditions, and developmental disorders like Noonan syndrome.
Synonyms include down regulation of signal transduction, inhibition of signal transduction, and negative regulation of signaling pathway.
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of negative regulators in signaling pathways.
Common models include mice, Drosophila, Arabidopsis, and bacterial systems like Bacillus subtilis.
SOCS proteins are induced by cytokines and feedback to inhibit JAK-STAT signaling, acting as critical negative regulators.
Cbl ubiquitin ligases ubiquitinate activated receptors, targeting them for degradation and terminating signaling.

Conclusion

Negative regulation of signal transduction (GO:0009968) is a fundamental biological process that ensures appropriate cellular responses to external and internal cues. Its dysregulation underlies numerous diseases, making it a rich area for research. By leveraging CRISPR-based models and advanced screening technologies, scientists can uncover new negative regulators and therapeutic targets. EDITGENE supports these efforts with tailored gene editing and bioinformatics services.

References

  1. 1. Cheng MC et al.. 2021. Phytochrome Signaling Networks.. Annu Rev Plant Biol 72:217-244 PMID: 33756095
  2. 2. Choi SC et al.. 2011. Negative regulation of activin signal transduction.. Vitam Horm 85:79-104 PMID: 21353877
  3. 3. Yasukawa H et al.. 2000. Negative regulation of cytokine signaling pathways.. Annu Rev Immunol 18:143-64 PMID: 10837055
  4. 4. Shibuya M et al.. 2006. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.. Exp Cell Res 312(5):549-60 PMID: 16336962
  5. 5. Hulett FM. 1996. The signal-transduction network for Pho regulation in Bacillus subtilis.. Mol Microbiol 19(5):933-9 PMID: 8830274
  6. 6. Ryan PE et al.. 2006. Regulating the regulator: negative regulation of Cbl ubiquitin ligases.. Trends Biochem Sci 31(2):79-88 PMID: 16406635
  7. 7. Aggarwal K et al.. 2008. Positive and negative regulation of the Drosophila immune response.. BMB Rep 41(4):267-77 PMID: 18452646
  8. 8. Zhu Y et al.. 2021. Analysis of Phytohormone Signal Transduction in Sophora alopecuroides under Salt Stress.. Int J Mol Sci 22(14) PMID: 34298928
Contact Us
*
*
*
*
How did you hear about us: